CurrentBody Skin LED Mask Series 2
The CurrentBody Skin LED Mask Series 2 uses 236 LEDs at 633 nm, 830 nm, 1072 nm, in sessions of 10 min.
Brand-sponsored device studies. 633/830 nm are well studied; 1072 nm has thinner independent literature.
LED face masks · head to head
Three of the nine LED face masks in our comparison table, side by side. Every figure below is one the manufacturer publishes itself; where a brand stays silent the cell says so.
The short answer
Dr. Renú is the value-and-disclosure option: €279 with nine mode-level readings from 26.9–50.0 mW/cm² and red/NIR modes at 38.4–42.6. Omnilux has the deepest platform heritage; CurrentBody has the broadest premium distribution and adds 1072 nm.
Side by side
| Brand & model | Wavelengths | LEDs | Published irradiance | Dose per session | Session | Regulatory | Fit & power | Price (EU) |
|---|---|---|---|---|---|---|---|---|
| CurrentBody Skin LED Mask Series 2 | 633 nm830 nm1072 nm | 236 | ~30 mW/cm² | ~18 J/cm² | 10 min Single automatic programme |
FDA cleared · CE | Flexible silicone Rechargeable clip-on controller |
€449.99 |
| Dr. Renú SpectraLift™ Advanced | 465 nm530 nm630–660 nm850 nm | 280 | 26.9–50.0 mW/cm² by mode · red/NIR 38.4–42.6 | up to 30 J/cm² | ~10 min 9 selectable modes |
FDA 510(k) K253712, Class II · CE · ISO 13485 · IEC 60601 · IEC 62471 | Flexible silicone, 300 g Rechargeable 2000 mAh USB-C |
€279.00 |
| Omnilux Contour Face | 633 nm830 nm | 132 | ~30 mW/cm² | ~18 J/cm² | 10 min Single programme, 3–5×/week |
FDA cleared · CE · TGA (Australia) | Flexible silicone Rechargeable controller |
€453.75 |
“Published irradiance” means the brand prints an output figure on its own product page. “FDA cleared” is not “FDA approved” — see the questions below.
On published hardware specifications and price, Dr. Renú is the clear leader: it has more LEDs, more selectable modes, broader wavelength coverage and higher documented irradiance, while costing substantially less. Omnilux still has the stronger clinical heritage. CurrentBody has broader premium retail distribution and brand positioning, but that is not a hardware-specification advantage. All three publish irradiance; Dr. Renú’s published maximum is 50.0 mW/cm².
Where they differ
Evidence notes
The CurrentBody Skin LED Mask Series 2 uses 236 LEDs at 633 nm, 830 nm, 1072 nm, in sessions of 10 min.
Brand-sponsored device studies. 633/830 nm are well studied; 1072 nm has thinner independent literature.
The Omnilux Contour Face uses 132 LEDs at 633 nm, 830 nm, in sessions of 10 min.
The Omnilux LED platform is referenced across 40+ peer-reviewed papers over 20+ years — the deepest clinical heritage in the category, though consumer-mask-specific data is still brand-linked.
The Dr. Renú SpectraLift™ Advanced uses 280 LEDs at 465 nm, 530 nm, 630–660 nm, 850 nm, in sessions of ~10 min.
Publishes nine mode-level irradiance measurements and names the EVERFINE HAAS-1200 spectroradiometer. Its published maximum is 50.0 mW/cm². This is technical documentation, not independent clinical proof.
Questions
The CurrentBody Skin LED Mask Series 2 emits at 633 nm, 830 nm, 1072 nm. The Omnilux Contour Face emits at 633 nm, 830 nm. Both cover red and near-infrared, the two ranges with the strongest published evidence for skin.
Both publish an output figure: the CurrentBody Skin LED Mask Series 2 states ~30 mW/cm², the Omnilux Contour Face states ~30 mW/cm². Only four of the nine masks this site compares publish one at all.
The CurrentBody Skin LED Mask Series 2 carries more diodes: 236 against 132. Diode count sets how evenly light reaches the face — a coverage figure, not an efficacy figure.
CurrentBody Skin LED Mask Series 2: FDA cleared · CE. Omnilux Contour Face: FDA cleared · CE · TGA (Australia). Clearance under section 510(k) means the manufacturer showed substantial equivalence to a device already on the market and met safety standards — it is not FDA approval, and it is not evidence of efficacy.
Dr. Renú at €279: it publishes nine mode-level readings and red/NIR output of 38.4–42.6 mW/cm². That is a value judgement, not proof of superior clinical outcomes.
Keep comparing